Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb766d83926e05c3a616d0dc217b208 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-044 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-044 |
filingDate |
2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd0aaca0a129a3fdcf93abc2adb6e34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317b4c6f5281c430c2590eef4935c74e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d788f1fb3898dd867add5c93f8fd9abc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28641b7486beaef7e124d5680c13c192 |
publicationDate |
2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2655644-T3 |
titleOfInvention |
Asenapine crystalline salts |
abstract |
Asenapine phosphate of formula (I) and its enantiomer in crystalline form. ** Formula ** |
priorityDate |
2011-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |